Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma

International Journal of Colorectal Disease

Volumn 22, Issue 10, 2007, Pages 1165-1172

  Daniel, Piotr ^a   Wagrowska Danilewicz, Malgorzata ^a   Danilewicz, Marian ^a   Stasikowska, Olga ^a   Malecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colorectal adenoma; Colorectal cancer (CC); KI 67; Metalloproteinase 9 (MMP9); Transforming growth factor beta 1 (TGFbeta1)

Indexed keywords

KI 67 ANTIGEN; METALLOPROTEINASE; METALLOPROTEINASE 9; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER GRADING; CARCINOGENESIS; COLON BIOPSY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOMA; AGED; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34548147720     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0296-9     Document Type: Article

References (52)

1. Sehgal I, Baley AP, Thompson T (1996) Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res 56:3359-3365
2. Bellone G, Carbone A, Tibaudi D, Mauri F, Ferrero I, Smirne C, Suman F, Rivetti C, Migliaretti G, Camandona M, Palestro G, Emmanueli G, Rodeck U (2001) Differential expression of transforming growth factors-β1, -β2, -β3 in human colon carcinoma. Eur J Cancer 37:224-233
3. Massague J (1998) TGF β signal transduction. Annu Rev Biochem 67:753-791
4. Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, Yanagitani S, Amoh Y, Takemoto H, Ogata N, Yamamoto C, Kubota Y, Seki Y, Inokuchi H, Nishizawa M, Takada H, Suwamura T, Okamura A, Inoue K (1999) Down-regulation of TGF β receptors in human colorectal cancer: implications for cancer development. Br J Cancer 80(1/2):194-205
5. Blobe G, Schieman W, Lodish H (2000) Role of transforming growth factor β in human disease. New Engl J Med 342:1350-1358
6. Ravitz MJ, Wenner CE (1997) Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF β. Adv Cancer Res 71:165-207
7. Villanueva A, Garcia C, Paules AB, Vincente M, Megias M, Reyes G, de Villalonga P, Agell N, Lluis F, Bachs Q, Capella G (1998) Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene 17:1969-1978
8. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S (1999) Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res 59:320-324
9. Roberts AB, Wakefield LM (2003) The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci USA 100:8621-8623
10. Galliher AJ, Neil JR, Schieman WP (2006) Role of transforming growth factor beta in cancer progression. Future Oncol 2(6):743-763
11. Pardali K, Moustakas A (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775(1):21-62
12. Zeng ZS, Guillem GJ (1995) Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72:575-582
13. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270
14. Bernahrd EJ, Muschel RJ, Huges EN (1990) Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872-3877
15. Yamagata S, Tanaka R, Ito Y, Shimuzu S (1989) Gelatinases of murine metastatic tumor cells. Biochem Biophys Res Commun 158:228-234
16. Mook OR, Frederix WM, Van Noorden CJ (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 17;1705(2):69-89
17. Brown P, Bloxidge R, Stuart S, Gatter K, Carmichael J (1993) Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85:574-578
18. Brown P, Bloxidge RE, Anderson E, Howel A (1993) Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11:183-189
19. Naylor MS, Stamp GW, Davies BD, Balkwill FR (1994) Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58:50-56
20. Satoh K, Ohtani H, Shimosegawa T, Kaizumi M, Sawai T, Toyota T (1994) Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 107:1488-1495
21. Ennis BW, Matrisian LM (1994) Matrix degrading metalloproteinases. J Neurooncol 18:105-109
22. Salminen E, Palmu S, Vahlberg T, Roberts PJ, Sodersttrom KO (2005) Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto-sigmoid cancer. World J Gastroenterol 11(21):3245-3249
23. Ishida H, Sadahiro S, Suzuki T (2003) Proliferative, infiltrative and metastatic activities in colorectal tumors assessed by MIB-1 antibody. Oncol Rep 10(6):1741-1745
24. Valera V, Yokoyama N, Walter B, Okamoto H, Suda T, Hatekeyama K (2005) Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma. Br J Surg 92:1002-1007
25. Baker EA, Leaper DJ (2002) Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 28(1):24-29
26. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni WF (1991) Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Path 4(2):267-280
27. Cardillo MB, Yap E (1997) TGFbeta1 in colonic neoplasia: A genetic molecular and immunohistochemical study. J Exp Clin Cancer Res 16(3):281-288
28. Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, Yanagitani S, Amoh Y, Takemoto H, Ogata N, Yamamoto C, Kubota Y, Seki T, Inokuchi H, Nishizawa M, Takada H, Sawamura T, Okamura A, Inoue K (1999) Down-regulation of TGF beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer 80(1/2):194-205
29. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ (1998) Gelatinase (MMP-2 and MMP-9) expression in gastrointestinal malignancy. Br J Cancer 78(11):1495-1502
30. Tomita T, Iwata K (1996) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 39:1255-1264
31. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley, New York
32. Hamilton SR, Aaltonen LA (2000) WHO classification of tumors pathology and genetics. Tumors of the digestive system. IARC Press, Lyon
33. Xiong B, Yuan HY, Hu MB, Zhang F, Wei ZZ, Gong LL, Yang GL (2002) Transforming growth factor beta 1 in invasion and metastasis in colorectal cancer. World J Gastroenterol 8(4):674-678
34. Roberts AB, Wakefield LK (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100(15):8621-8630
35. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M (1993) TGF beta expression in the human colon: Differential immunostaining along crypt epithelium. Br J Cancer 68:137-139
36. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S, Sugimachi K (1999) Role of transforming growth factor beta in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607-614
37. Von Rahden BH, Stein HJ, Feith M, Puhringer F, Thiesen J, Siewert JR, Sarbie M (2006) Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 45(10):786-794
38. Robson H, Anderson E, James RD, Shofield PF (1996) Transforming growth factor beta 1 expression in human colorectal tumors: An independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 74(5):753-758
39. Shimizu S, Nishikawa Y, Kuroda K, Takagi S, Kozaki K, Hyuga S, Saga S, Matsuyama M (1996) Involvement of transforming growth factor beta 1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 56:366-3370
40. Berger DH, O'Mahony CA, Sheng H, Shao J, Albo D, DuBois RN, Beauchamp RD (2003) Intestinal transformation results in transforming growth factor beta-dependent alteration in tumor cell-cell matrix interaction. Surgery 133(5):568-579
41. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ (1998) Gelatinase (MMP-2 and MMP-9) expression in gastrointestinal malignancy. Br J Cancer 78(11):1495-1502
42. Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorogenesis. Carcinogenesis 20(5):749-755
43. Tomita T, Iwata K (1996) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 39:1255-1264
44. Moran A, Iniesta P, Garcia Avanda C, De Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres Aj, Diaz-Rubio E, Balibrea JL, Benito M (2005) Clinical relevance of MMP9, MMP2, TIMP-1, and TIMP-2 in colorectal cancer. Oncol Rep 13(1):115-120
45. Saleh H, Jackson H, Khatib G, Banerjee M (1999) Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia. Pathol Oncol Res 5(4):273-279
46. Johnston PG, O'Brien MJ, Dervan PA, Carney DN (1989) Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 20(7):696-700
47. Saleh HA, Jackson H, Banerjee M (2000) Immunohiostochemical expression of bcl-2 and p53 oncoproteins: Correlation with Ki-67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia. Appl Immunohistochem Mol Morphol 8(3):175-182
48. Suzuki H, Matsumoto K, Terobe M (1992) Ki-67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol 15(4):317-320
49. Kyzer S, Gordon PH (1997) Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki67. Dis Colon Rectum 40(3):322-325
50. Porshen R, Lohe B, Hengels KJ, Borchard F (1989) Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67. Correlation with pathohistologic criteria and influence of irridation. Cancer 64(12):2501-2505
51. Oshima CT, Iriya K, Forones NM (2005) Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer. Neoplasma 52(5):420-424
52. Jansson A, Sun XF (1997) Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas. APMIS 105(9):730-734